Promising Early Data for Improving Talquetamab Effectiveness for MM | Tarek Mouhieddine, MD

11 Views

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Published Jan 17, 2025

Promising drug synergies found in the lab setting set the stage for future clinical trials.

Link to ASH playlist: https://healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b

ASH Abstract: Combined PD-1 and Tim-3 Blockade Improves the in Vitro Anti-Myeloma Activity of T Cells of Patients on Talquetamab
#ASH24 #myeloma #leusm

Follow HealthTree: https://linktr.ee/HealthTreeUniversity